BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Fundamental Analysis & Valuation

FRA:BRYN • US0846707026

Current stock price

412.5 EUR
-1.55 (-0.37%)
Last:

This BRYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. BRYN.DE Profitability Analysis

1.1 Basic Checks

  • BRYN had positive earnings in the past year.
  • In the past year BRYN had a positive cash flow from operations.
  • Of the past 5 years BRYN 4 years were profitable.
  • Each year in the past 5 years BRYN had a positive operating cash flow.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B -20B 40B 60B 80B

1.2 Ratios

  • BRYN's Return On Assets of 5.48% is amongst the best of the industry. BRYN outperforms 81.82% of its industry peers.
  • BRYN's Return On Equity of 9.33% is fine compared to the rest of the industry. BRYN outperforms 65.45% of its industry peers.
  • The Return On Invested Capital of BRYN (4.17%) is better than 61.82% of its industry peers.
  • BRYN had an Average Return On Invested Capital over the past 3 years of 4.29%. This is below the industry average of 8.81%.
Industry RankSector Rank
ROA 5.48%
ROE 9.33%
ROIC 4.17%
ROA(3y)7.4%
ROA(5y)5.83%
ROE(3y)13.39%
ROE(5y)10.63%
ROIC(3y)4.29%
ROIC(5y)3.99%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • BRYN's Profit Margin of 18.03% is fine compared to the rest of the industry. BRYN outperforms 72.73% of its industry peers.
  • In the last couple of years the Profit Margin of BRYN has remained more or less at the same level.
  • The Operating Margin of BRYN (15.63%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of BRYN has grown nicely.
  • The Gross Margin of BRYN (24.75%) is worse than 60.00% of its industry peers.
  • In the last couple of years the Gross Margin of BRYN has grown nicely.
Industry RankSector Rank
OM 15.63%
PM (TTM) 18.03%
GM 24.75%
OM growth 3Y5.77%
OM growth 5Y5.73%
PM growth 3YN/A
PM growth 5Y0.81%
GM growth 3Y5.1%
GM growth 5Y2.53%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BRYN.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BRYN is still creating some value.
  • Compared to 1 year ago, BRYN has about the same amount of shares outstanding.
  • Compared to 5 years ago, BRYN has less shares outstanding
  • The debt/assets ratio for BRYN has been reduced compared to a year ago.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B 1T

2.2 Solvency

  • BRYN has an Altman-Z score of 1.37. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
  • BRYN has a Altman-Z score of 1.37. This is comparable to the rest of the industry: BRYN outperforms 60.00% of its industry peers.
  • The Debt to FCF ratio of BRYN is 5.15, which is a neutral value as it means it would take BRYN, 5.15 years of fcf income to pay off all of its debts.
  • BRYN has a Debt to FCF ratio of 5.15. This is in the better half of the industry: BRYN outperforms 67.27% of its industry peers.
  • BRYN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • BRYN has a Debt to Equity ratio of 0.18. This is in the better half of the industry: BRYN outperforms 67.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.15
Altman-Z 1.37
ROIC/WACC1.25
WACC3.32%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B

2.3 Liquidity

  • BRYN has a Current Ratio of 1.36. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.36, BRYN perfoms like the industry average, outperforming 50.91% of the companies in the same industry.
  • A Quick Ratio of 1.09 indicates that BRYN should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.09, BRYN is in line with its industry, outperforming 43.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.09
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BRYN.DE Growth Analysis

3.1 Past

  • The earnings per share for BRYN have decreased by -6.25% in the last year.
  • The Earnings Per Share has been growing by 17.67% on average over the past years. This is quite good.
  • BRYN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.00%.
  • Measured over the past years, BRYN shows a quite strong growth in Revenue. The Revenue has been growing by 8.63% on average per year.
EPS 1Y (TTM)-6.25%
EPS 3Y13.85%
EPS 5Y17.67%
EPS Q2Q%-29.78%
Revenue 1Y (TTM)0%
Revenue growth 3Y7.14%
Revenue growth 5Y8.63%
Sales Q2Q%-0.72%

3.2 Future

  • BRYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.50% yearly.
  • Based on estimates for the next years, BRYN will show a small growth in Revenue. The Revenue will grow by 5.94% on average per year.
EPS Next Y7.31%
EPS Next 2Y4.96%
EPS Next 3Y4.08%
EPS Next 5Y4.5%
Revenue Next Year-4.59%
Revenue Next 2Y-0.68%
Revenue Next 3Y-0.49%
Revenue Next 5Y5.94%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10K 20K 30K

More info and screens

Find the best growth stocksShow best growing peers

9

4. BRYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • BRYN is valuated cheaply with a Price/Earnings ratio of 0.02.
  • Based on the Price/Earnings ratio, BRYN is valued cheaply inside the industry as 98.18% of the companies are valued more expensively.
  • BRYN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.21.
  • With a Price/Forward Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, BRYN is valued cheaply inside the industry as 98.18% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, BRYN is valued rather cheaply.
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BRYN is valued cheaper than 89.09% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BRYN is valued cheaply inside the industry as 98.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.03
EV/EBITDA 1.04
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K 400K

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of BRYN may justify a higher PE ratio.
PEG (NY)0
PEG (5Y)0
EPS Next 2Y4.96%
EPS Next 3Y4.08%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BRYN.DE Dividend Analysis

5.1 Amount

  • No dividends for BRYN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BRYN.DE Fundamentals: All Metrics, Ratios and Statistics

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (4/7/2026, 9:22:45 AM)

412.5

-1.55 (-0.37%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-02
Earnings (Next)05-01
Inst Owners30.29%
Inst Owner ChangeN/A
Ins Owners37.74%
Ins Owner ChangeN/A
Market Cap594.00M
Revenue(TTM)371.44B
Net Income(TTM)66.97B
Analysts44
Price Target442.96 (7.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.53%
Min EPS beat(2)-15.88%
Max EPS beat(2)4.81%
EPS beat(4)2
Avg EPS beat(4)-5.16%
Min EPS beat(4)-15.88%
Max EPS beat(4)4.81%
EPS beat(8)5
Avg EPS beat(8)5.49%
EPS beat(12)8
Avg EPS beat(12)6.31%
EPS beat(16)11
Avg EPS beat(16)6.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.41%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)0.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)0.72%
Revenue beat(8)2
Avg Revenue beat(8)-1.86%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)6
Avg Revenue beat(16)-0.79%
PT rev (1m)0%
PT rev (3m)-1.8%
EPS NQ rev (1m)-1.39%
EPS NQ rev (3m)-1.39%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-3.85%
Revenue NQ rev (3m)-3.92%
Revenue NY rev (1m)-4.18%
Revenue NY rev (3m)-4.31%
Valuation
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
P/S 0
P/FCF 0.03
P/OCF 0.01
P/B 0
P/tB 0
EV/EBITDA 1.04
EPS(TTM)26839.33
EY6506.5%
EPS(NY)28801.88
Fwd EY6982.27%
FCF(TTM)15089.2
FCFY3657.99%
OCF(TTM)27698.8
OCFY6714.86%
SpS223815.38
BVpS432284.29
TBVpS361233
PEG (NY)0
PEG (5Y)0
Graham Number510930
Profitability
Industry RankSector Rank
ROA 5.48%
ROE 9.33%
ROCE 5.14%
ROIC 4.17%
ROICexc 4.37%
ROICexgc 5.16%
OM 15.63%
PM (TTM) 18.03%
GM 24.75%
FCFM 6.74%
ROA(3y)7.4%
ROA(5y)5.83%
ROE(3y)13.39%
ROE(5y)10.63%
ROIC(3y)4.29%
ROIC(5y)3.99%
ROICexc(3y)4.49%
ROICexc(5y)4.21%
ROICexgc(3y)5.35%
ROICexgc(5y)5.06%
ROCE(3y)5.29%
ROCE(5y)4.92%
ROICexgc growth 3Y2.7%
ROICexgc growth 5Y6.05%
ROICexc growth 3Y3.93%
ROICexc growth 5Y7.05%
OM growth 3Y5.77%
OM growth 5Y5.73%
PM growth 3YN/A
PM growth 5Y0.81%
GM growth 3Y5.1%
GM growth 5Y2.53%
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.15
Debt/EBITDA 1.8
Cap/Depr 155.29%
Cap/Sales 5.63%
Interest Coverage 11.39
Cash Conversion 64.28%
Profit Quality 37.39%
Current Ratio 1.36
Quick Ratio 1.09
Altman-Z 1.37
F-Score5
WACC3.32%
ROIC/WACC1.25
Cap/Depr(3y)152.78%
Cap/Depr(5y)144.82%
Cap/Sales(3y)5.36%
Cap/Sales(5y)5.2%
Profit Quality(3y)27.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.25%
EPS 3Y13.85%
EPS 5Y17.67%
EPS Q2Q%-29.78%
EPS Next Y7.31%
EPS Next 2Y4.96%
EPS Next 3Y4.08%
EPS Next 5Y4.5%
Revenue 1Y (TTM)0%
Revenue growth 3Y7.14%
Revenue growth 5Y8.63%
Sales Q2Q%-0.72%
Revenue Next Year-4.59%
Revenue Next 2Y-0.68%
Revenue Next 3Y-0.49%
Revenue Next 5Y5.94%
EBIT growth 1Y-4.75%
EBIT growth 3Y13.32%
EBIT growth 5Y14.85%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.58%
FCF growth 3Y4.59%
FCF growth 5Y-1.32%
OCF growth 1Y50.26%
OCF growth 3Y7.17%
OCF growth 5Y2.94%

BERKSHIRE HATHAWAY INC-CL B / BRYN.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BERKSHIRE HATHAWAY INC-CL B?

ChartMill assigns a fundamental rating of 5 / 10 to BRYN.DE.


What is the valuation status of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

ChartMill assigns a valuation rating of 9 / 10 to BERKSHIRE HATHAWAY INC-CL B (BRYN.DE). This can be considered as Undervalued.


How profitable is BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for BRYN stock?

The Earnings per Share (EPS) of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is expected to grow by 7.31% in the next year.